Mizuho Cuts DENTSPLY SIRONA (NASDAQ:XRAY) Price Target to $18.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price lowered by Mizuho from $21.00 to $18.00 in a research report released on Thursday morning,Benzinga reports. The brokerage currently has a neutral rating on the medical instruments supplier’s stock.

Other analysts also recently issued research reports about the company. Wells Fargo & Company decreased their target price on DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating on the stock in a research note on Friday, February 28th. Morgan Stanley reduced their price objective on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research report on Tuesday, December 17th. Robert W. Baird dropped their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research report on Friday, February 28th. UBS Group reduced their price target on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a report on Tuesday, December 3rd. Finally, Evercore ISI reissued an “in-line” rating and set a $20.00 price objective on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Twelve equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $23.33.

DENTSPLY SIRONA Trading Up 3.7 %

Shares of DENTSPLY SIRONA stock opened at $15.56 on Thursday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The company has a fifty day moving average of $18.22 and a 200 day moving average of $20.83. The company has a market capitalization of $3.10 billion, a P/E ratio of -7.52, a P/E/G ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA has a fifty-two week low of $14.77 and a fifty-two week high of $33.72.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be paid a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 4.11%. DENTSPLY SIRONA’s payout ratio is currently -14.07%.

Insider Activity

In other news, Director Gregory T. Lucier purchased 15,142 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The stock was purchased at an average cost of $16.51 per share, with a total value of $249,994.42. Following the purchase, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.52% of the company’s stock.

Institutional Trading of DENTSPLY SIRONA

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in XRAY. Colonial Trust Co SC purchased a new position in shares of DENTSPLY SIRONA during the fourth quarter valued at approximately $26,000. Riverview Trust Co purchased a new position in DENTSPLY SIRONA during the 4th quarter valued at $26,000. MassMutual Private Wealth & Trust FSB boosted its holdings in DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after acquiring an additional 1,232 shares during the period. UMB Bank n.a. grew its position in DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock valued at $28,000 after acquiring an additional 564 shares during the last quarter. Finally, Van ECK Associates Corp purchased a new stake in DENTSPLY SIRONA in the third quarter worth $42,000. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.